THOMAS CAWLEY: Open Payments
NPI 1568866010 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,032 in 124 payments from 32 companies in 2025. Trend: 2023 $1,561 · 2024 $2,166 · 2025 $2,032
Food & beverage: $2,032
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $262 |
| ABBVIE INC. | 25 | $238 |
| Amgen Inc. | 22 | $175 |
| PFIZER INC. | 10 | $169 |
| Phathom Pharmaceuticals, Inc. | 3 | $150 |
| Lilly USA, LLC | 9 | $134 |
| Novo Nordisk Inc | 4 | $85 |
| Abbott Laboratories | 4 | $69 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| GlaxoSmithKline, LLC. | 4 | $68 |
Products named: VOQUEZNA, FARXIGA, AIRSUPRA, UBRELVY, OTEZLA, NURTEC ODT, MOUNJARO, EVENITY.
Industry payments across VA — which companies pay providers there.
